RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (RYTM)

CUSIP: 76243J105

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
-2,876,768
Put/Call ratio
0%
SEC-reported price per share
$4.15
Number of holders
82
Value change
-$18,795,957
Number of buys
38
Open additional details 1 more signal available
Number of sells
62
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
69,012,275

Security key

76243J105

Report period

Q2 2022

Institutions

82

Top holders

10

Ownership snapshot

Top reported holders of RYTM - RHYTHM PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRIMECAP MANAGEMENT CO/CA/
Disclosed value leader
PRIMECAP MANAGEMENT CO/CA/
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F Lead comparable stake: 9.1% Showing 1-6 of 15 holder rows.

Quick read

PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 9.1%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Comparable ownership Top 5
PRIMECAP MANAGEMENT CO/CA/ 9.1%
FEDERATED HERMES, INC. 7.3%
NEA Management Company, LLC 7.1%
RA CAPITAL MANAGEMENT, L.P. 7.1%
BAKER BROS. ADVISORS LP 6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
9.1%
$72,484,000
6,291,991 shares
31 Mar 2022
FEDERATED HERMES, INC.
13F
Company
13F
7.3%
$58,350,000
5,065,113 shares
31 Mar 2022
NEA Management Company, LLC
13F
Company
13F
7.1%
$56,590,000
4,912,306 shares
31 Mar 2022
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
7.1%
$56,115,000
4,871,067 shares
31 Mar 2022
BAKER BROS. ADVISORS LP
13F
Company
13F
6%
$47,521,000
4,125,062 shares
31 Mar 2022
GOLDMAN SACHS GROUP INC
13F
Company
13F
4.8%
$38,474,000
3,339,750 shares
31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
82
Shares
45,934,145
Rows available
82
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
105
Q2 2022 holders
82
Holder diff
-23
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .